INDSWFTLAB

Ind-Swift Laboratories Share Price

 

 

Start SIP in INDSWFTLAB

Start SIP

Performance

  • Low
  • ₹95
  • High
  • ₹100
  • 52 Week Low
  • ₹69
  • 52 Week High
  • ₹124
  • Open Price₹97
  • Previous Close₹96
  • Volume169,002

Investment Returns

  • Over 1 Month -5.27%
  • Over 3 Month -9.61%
  • Over 6 Month -11.21%
  • Over 1 Year -17.07%

Smart Investing Starts Here Start SIP with Ind-Swift Laboratories for Steady Growth!

Invest Now

Ind-Swift Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 3.3
  • PEG Ratio
  • -0.4
  • Market Cap Cr
  • 799
  • P/B Ratio
  • Average True Range
  • 4.08
  • EPS
  • 3.63
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.9
  • RSI
  • 51.93
  • MFI
  • 56.72

Ind-Swift Laboratories Financials

Ind-Swift Laboratories Technicals

EMA & SMA

Current Price
₹97.91
+ 2.16 (2.26%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹96.16
  • 50 Day
  • ₹98.65
  • 100 Day
  • ₹99.65
  • 200 Day
  • ₹100.62

Resistance and Support

97.41 Pivot Speed
  • R3 104.69
  • R2 102.10
  • R1 100.00
  • S1 95.31
  • S2 92.72
  • S3 90.62

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ind-Swift Labs. (Nse) has an operating revenue of Rs. 452.28 Cr. on a trailing 12-month basis. An annual revenue de-growth of -52% needs improvement, Pre-tax margin of 46% is great, ROE of 21% is exceptional. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 99 which is a GREAT score indicating consistency in earnings, a RS Rating of 48 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ind-Swift Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results
2025-08-11 Audited Results
2025-05-30 Audited Results
2025-02-13 Quarterly Results (Revised)

Ind-Swift Laboratories F&O

Ind-Swift Laboratories Shareholding Pattern

39.5%
0%
0%
14.8%
0%
34.96%
10.74%

About Ind-Swift Laboratories

  • NSE Symbol
  • INDSWFTLAB
  • BSE Symbol
  • 532305
  • Chairman & Managing Director
  • Mr. Navrattan Munjal
  • ISIN
  • INE915B01019

Similar Stocks to Ind-Swift Laboratories

Ind-Swift Laboratories FAQs

Ind-Swift Laboratories share price is ₹97 As on 13 December, 2025 | 05:36

The Market Cap of Ind-Swift Laboratories is ₹799.1 Cr As on 13 December, 2025 | 05:36

The P/E ratio of Ind-Swift Laboratories is 3.3 As on 13 December, 2025 | 05:36

The PB ratio of Ind-Swift Laboratories is 0.8 As on 13 December, 2025 | 05:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23